Suppr超能文献

加拿大安大略省娱乐用大麻合法化、商业化与因大麻就诊的急诊科人次之间的关联:一项中断时间序列分析

The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.

作者信息

Myran Daniel T, Pugliese Michael, Tanuseputro Peter, Cantor Nathan, Rhodes Emily, Taljaard Monica

机构信息

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.

出版信息

Addiction. 2022 Jul;117(7):1952-1960. doi: 10.1111/add.15834. Epub 2022 Feb 17.

Abstract

BACKGROUND AND AIMS

Recreational cannabis was legalized in Canada in October 2018. Initially, the Government of Ontario (Canada's largest province) placed strict limits on the number of cannabis retail stores before later removing these limits. This study measured changes in cannabis-attributable emergency department (ED) visits over time, corresponding to different regulatory periods.

DESIGN

Interrupted time-series design using population-level data. Two policy periods were considered; recreational cannabis legalization with strict store restrictions (RCL, 17 months) and legalization with no store restrictions [recreational cannabis commercialization (RCC), 15 months] which coincided with the COVID-19 pandemic. Segmented Poisson regression models were used to examine immediate and gradual effects in each policy period.

SETTING

Ontario, Canada.

PARTICIPANTS

All individuals aged 15-105 years (n = 13.8 million) between January 2016 and May 2021.

MEASUREMENTS

Monthly counts of cannabis-attributable ED visits per capita and per all-cause ED visits in individuals aged 15+ (adults) and 15-24 (young adults) years.

FINDINGS

We observed a significant trend of increasing cannabis-attributable ED visits pre-legalization. RCL was associated with a significant immediate increase of 12% [incident rate ratio (IRR) = 1.12, 95% confidence interval (CI) = 1.02-1.23] in rates of cannabis-attributable ED visits followed by significant attenuation of the pre-legalization slope (monthly slope change IRR = 0.98, 95% CI = 0.97-0.99). RCC and COVID-19 were associated with immediate significant increases of 22% (IRR = 1.22, 95% CI = 1.09-1.37) and 17% (IRR = 1.17, 95% CI = 1.00-1.37) in rates of cannabis-attributable visits and the proportion of all-cause ED visits attributable to cannabis, respectively, with insignificant increases in monthly slopes. Similar patterns were observed in young adults.

CONCLUSIONS

In Ontario, Canada, cannabis-attributable emergency department visits stopped increasing over time following recreational cannabis legalization with strict retail controls but then increased during a period coinciding with cannabis commercialization and the COVID-19 pandemic.

摘要

背景与目的

2018年10月,娱乐用大麻在加拿大实现合法化。最初,安大略省政府(加拿大最大的省份)对大麻零售店的数量设定了严格限制,随后取消了这些限制。本研究测量了在不同监管时期,因大麻导致的急诊科就诊人数随时间的变化。

设计

使用人群水平数据的中断时间序列设计。考虑了两个政策时期;有严格店铺限制的娱乐用大麻合法化时期(RCL,17个月)和无店铺限制的合法化时期[娱乐用大麻商业化时期(RCC),15个月],这一时期恰逢新冠疫情。采用分段泊松回归模型来检验每个政策时期的即时和渐进影响。

地点

加拿大安大略省。

参与者

2016年1月至2021年5月期间所有年龄在15 - 105岁的个体(n = 1380万)。

测量指标

15岁及以上(成年人)和15 - 24岁(年轻人)个体中,人均因大麻导致的急诊科就诊次数以及所有病因导致的急诊科就诊次数中因大麻导致的就诊次数占比的月度计数。

研究结果

我们观察到在合法化之前,因大麻导致的急诊科就诊次数有显著增加的趋势。RCL与因大麻导致的急诊科就诊率立即显著增加12%[发病率比(IRR)= 1.12,95%置信区间(CI)= 1.02 - 1.23]相关,随后合法化前的斜率显著衰减(月度斜率变化IRR = 0.98,95% CI = 0.97 - 0.99)。RCC和新冠疫情分别与因大麻导致的就诊率立即显著增加22%(IRR = 1.22,95% CI = 1.09 - 1.37)以及所有病因导致的急诊科就诊次数中因大麻导致的就诊比例立即显著增加17%(IRR = 1.17,95% CI = 1.00 - 1.37)相关,月度斜率增加不显著。在年轻人中也观察到了类似的模式。

结论

在加拿大安大略省实行严格零售管控的娱乐用大麻合法化后,因大麻导致的急诊科就诊次数随时间停止增加,但在与大麻商业化和新冠疫情同时发生的时期又有所增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验